Clinical Trial Update: Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating routine use of a potassium competitive acid blocker versus guideline-directed gastrointestinal protection in patients with acute myoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Bleeding
• Myocardial Infarction

Drugs mentioned

• Potassium-Competitive Acid Blocker (potassium-competitive acid blocker)

Snippet

Sponsor: Samsung Medical Center | Conditions: Acute Myocardial Infarction (AMI), Gastrointestinal Bleeding | Phase 4 | Status: NOT_YET_RECRUITING